Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-10 Option Award |
2024-06-11 4:12 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Lawton Alison Frances Director |
45,000 | $0 | 96,667 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 7:58 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Lawton Alison Frances Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 9:17 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | Lawton Alison Frances Director |
6,500 | $0 | 6,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-30 4:30 pm |
N/A 2033-06-22 |
Aeglea BioTherapeutics Inc. | AGLE | Lawton Alison Frances Director |
1,950,000 | $0 | 1,950,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 4:51 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Lawton Alison Frances Director |
45,000 | $0 | 51,667 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 6:36 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-27 4:17 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Lawton Alison Frances Director |
6,667 | $0 | 6,667 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-10 06:04 am |
N/A 2032-06-06 |
Aeglea BioTherapeutics Inc. | AGLE | Lawton Alison Frances Director |
43,000 | $0 | 43,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:24 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Lawton Alison Frances Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 6:36 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director |
18,188 | $0 | 18,188 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 5:02 pm |
N/A 2031-06-02 |
X4 Pharmaceuticals Inc | XFOR | Lawton Alison Frances Director |
6,000 | $9.5 | 6,000 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-23 7:13 pm |
N/A 2030-12-21 |
Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director |
36,377 | $0 | 36,377 (Direct) |
View |
Ownership |
2020-12-23 7:09 pm |
N/A 2027-09-26 |
Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director |
0 | $0 | 52,244 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:33 pm |
N/A 2030-12-14 |
Aeglea BioTherapeutics Inc. | AGLE | Lawton Alison Frances Director |
47,200 | $0 | 47,200 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-06 07:43 am |
N/A 2030-10-04 |
X4 Pharmaceuticals Inc | XFOR | Lawton Alison Frances Director |
6,854 | $0 | 6,854 (Direct) |
View |
Ownership |
2020-10-06 07:39 am |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Lawton Alison Frances Director |
0 | $0 | 10,134 (Direct) |
View |